Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Combination therapies might work better for some vitiligo patients, but results vary.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Clofazimine may be effective for treating ashy dermatosis.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Minoxidil can help regrow hair in alopecia areata patients.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.